Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cholecystokinin B receptor | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Agonist activity (functional) | 0 | Agonistic activity against gastrin induced acid secretion in the anesthetized rats at a dose of 3 mg/kg;*=1/4 of the agonistic activity | ChEMBL. | 3572963 |
ED50 (functional) | = 1.1 uM kg-1 | Effective dose required to inhibit gastrin-induced acid secretion in the in situ perfused rat stomach (anesthetized rat) | ChEMBL. | 3572963 |
IC50 (binding) | = 15 uM | In vitro inhibitory activity for binding of [125I]-(Nle11)-HG-13 to gastrin receptor on isolated rabbit gastric mucosal cells. | ChEMBL. | 3572963 |
IC50 (binding) | = 15 uM | In vitro inhibitory activity for binding of [125I]-(Nle11)-HG-13 to gastrin receptor on isolated rabbit gastric mucosal cells. | ChEMBL. | 3572963 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.